News from united neuroscience A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 28, 2019, 08:00 ET United Neuroscience to Present Data on Alzheimer's Vaccine at the 2019 AD/PD Conference

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced...


Jan 16, 2019, 08:10 ET United Neuroscience Announces Positive Top-Line Results from Phase 2a Clinical Study of UB-311 Vaccine in Patients with Alzheimer's Disease

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced...


Dec 21, 2018, 10:00 ET United Neuroscience Names Peter Powchik, M.D, Executive Vice President of Research & Development

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced...


Nov 13, 2018, 10:07 ET United Neuroscience Strengthens Vaccine Pipeline with Novel Immunotherapy for Parkinson's Disease

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced...


Oct 18, 2018, 11:00 ET United Neuroscience to Present Alzheimer's Vaccine Clinical Trial Update at CTAD 2018

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced...


Oct 16, 2018, 08:00 ET United Neuroscience Continues Growth with Addition of Five Executives to Management Team

United Neuroscience, Ltd., (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today...


Nov 13, 2017, 09:20 ET United Neuroscience to Present at CNS Summit 2017

United Neuroscience (UNS), a clinical stage biotechnology company dedicated to developing best-in-class therapies for Alzheimer's disease,...


Nov 01, 2017, 16:30 ET United Neuroscience Presents Data for Phase 2 Active Vaccine Program UB-311 at the Clinical Trials on Alzheimer's Disease 2017 Meeting

United Neuroscience (UNS), a clinical stage biotechnology company dedicated to developing best-in-class therapies for Alzheimer's disease (AD),...